Newsroom
Sorted by: Latest
-
KBRA Assigns Rating to Frontline Insurance Reciprocal Exchange
NEW YORK--(BUSINESS WIRE)--KBRA assigns a BBB+ Insurance Financial Strength Rating (IFSR) to Frontline Insurance Reciprocal Exchange (“FIRE” or the “Exchange”). The Outlook for the rating is Stable. Key Credit Considerations FIRE is a newly formed Florida-domiciled reciprocal insurer established to write admitted Florida residential property business, primarily homeowners and fire/dwelling coverage. The rating reflects adequate initial capitalization and manageable projected underwriting levera...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 5/22/2026 Issue ¦ Toyota Finance Australia Limited Series 338 EUR 200,000,000 FRN Due in May 2027 ISIN Number ¦ XS3355971840 ISIN Reference ¦ 335597184 Issue Nomin EUR ¦ 200000000 Period ¦ 5/26/2026 to 8/24/2026 Payment Date 8/24/2026 Number of Days ¦ 90 Rate ¦ 2.484 Denomination EUR ¦ 100000 ¦ 200000000 ¦ Amount Payable per Denomination ¦ 621 ¦ 1242000 ¦ Bank of New York...
-
Trecora to Increase Specialty Monomer Prices on Elevated Costs
THE WOODLANDS, Texas--(BUSINESS WIRE)--Trecora, a global leader in specialty materials, will increase the price of all grades of Specialty Monomers by the amounts listed below effective June 1, 2026, or as contracts permit. The increase is necessary due to higher input costs, higher operating costs and continued investment in safe and reliable operations. Vinyl Toluene: $0.10/lb Divinylbenzene: $0.15/lb Para-Methylstyrene: $0.15/lb Para-Tertiary-Butyl Styrene: $0.20/lb About Trecora Based in Th...
-
Deadline Alert: Sportradar Group AG (SRAD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Sportradar Group AG (“Sportradar” or the “Company”) (NASDAQ: SRAD) Class A ordinary shares between November 7, 2024, and April 21, 2026, inclusive (the “Class Period”).IF YOU SUFFERED A LOSS ON YOUR SPORTRADAR INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTI...
-
emeis : Programme de rachat de titres
PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Déclaration des transactions sur actions propres Période du 18 au 20 mai 2026 Emetteur : EMEIS (LEI : 969500LHIH3NT7PK1V89) (Paris:EMEIS) Catégories de titres : actions ordinaires (ISIN : FR001400NLM4) Descriptif du programme mis en ligne sur le site Internet de l’Autorité des Marchés Financiers le 21 mai 2026 Rapport hebdomadaire sur les rachats d'actions du 18 au 20 mai 2026 Nom de l'émetteur Code identifiant de l'émetteur (co...
-
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Commvault Systems Inc. (CVLT) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Commvault Systems Inc. (“Commvault” or the “Company”) (NASDAQ: CVLT) securities between April 29, 2025 and January 26, 2026, inclusive (the “Class Period”). Commvault investors have until July 17, 2026 to file a lead plaintiff motion.IF YOU SUFFERED A LO...
-
Baszucki Group、早期精神病向けケトジェニック療法に関するオックスフォード大学の臨床試験に助成
カリフォルニア州サンマテオ--(BUSINESS WIRE)--(ビジネスワイヤ) -- Baszucki Groupは本日、精神病に対する臨床的高リスク状態(CHR-P)にある患者を対象に、ケトジェニック食の実施可能性、安全性、有効性を評価するオックスフォード大学の無作為化比較試験を支援するため、117万ポンドの助成金の拠出を発表しました。研究者らは、この栄養療法が患者の精神的・身体的健康を改善できるかを検証します。本プロジェクトは、深刻な精神疾患の治療における代謝療法の可能性を示す研究知見の増加を踏まえたものです。 精神病性障害は当事者に非常に大きな負担をもたらし、平均余命の短縮とも関連しています。精神病は突然発症するわけではなく、通常は早期の軽微な症状が一定期間続いた後に現れます。この段階にある人々はCHR-Pに分類され、予防的介入が可能な重要な時機として位置づけられます。しかし、CHR-Pを検出するための診断ツールは十分に発達している一方で、治療選択肢は限られています。現在、CHR-P患者における本格的な精神病への移行率を低下させる特異的な適応治療は存在しておらず、新たな介入...
-
Baszucki Group financia un ensayo clínico de la Universidad de Oxford sobre terapia cetogénica para personas con riesgo elevado de psicosis
SAN MATEO, California--(BUSINESS WIRE)--Baszucki Group anunció hoy una subvención de 1,17 millones de libras esterlinas para financiar un ensayo clínico aleatorizado y controlado en la Universidad de Oxford, destinado a evaluar la viabilidad, seguridad y eficacia de una dieta cetogénica en personas con riesgo clínico elevado de psicosis (CHR-P, por sus siglas en inglés). Los investigadores analizarán la capacidad de esta intervención nutricional para mejorar la salud mental y física de los part...
-
Baszucki Group financia ensaio clínico da Universidade de Oxford sobre terapia cetogênica para psicose precoce
SAN MATEO, Califórnia--(BUSINESS WIRE)--O Baszucki Group anunciou hoje um subsídio de £1,17 milhões para apoiar um ensaio randomizado controlado na Universidade de Oxford, avaliando a viabilidade, a segurança e a eficácia de uma dieta cetogênica para pacientes com risco clínico elevado de psicose (RCE-P). Os pesquisadores testarão essa habilidade da terapia nutricional de melhorar a saúde mental e física dos pacientes. Esse projeto se desenvolve com base em um crescente corpo de pesquisas que s...
-
Samsung consolide ses investissements au Canada en étendant sa présence dans trois centres commerciaux de premier plan
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Samsung Canada announced the continued expansion of its national retail footprint with the upcoming openings of three new Samsung Experience Stores...